Infective endocarditis after isolated aortic valve replacement: comparison between catheter-interventional and surgical valve replacement

被引:2
|
作者
Ried, Isabelle D. [1 ]
Omran, Hazem [1 ]
Potratz, Max [1 ]
Rudolph, Tanja K. [1 ]
Scholtz, Smita [1 ]
Bleiziffer, Sabine [2 ]
Piper, Cornelia [1 ]
机构
[1] Ruhr Univ Bochum, Clin Gen & Intervent Cardiol Angiol, Herz & Diabet Zentrum NRW, Georgstr 11, D-32545 Bad Oeynhausen, Germany
[2] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany
关键词
Prosthetic valve endocarditis; TAVI; Surgical aortic valve replacement; Prosthetic heart valves; Endocarditis; Prognosis; CLINICAL PRESENTATION; IMPLANTATION; ETIOLOGY; OUTCOMES; RISK; TAVR;
D O I
10.1007/s00392-023-02356-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims Prosthetic valve endocarditis (PVE) is the prognostically most unfavourable complication after aortic valve replacement. This study aims to contribute to a better understanding of the different pathological and therapeutical aspects between PVE following surgical (SAVR) and transcatheter aortic valve replacement (TAVI).Methods All patients who had undergone primary isolated SAVR (n = 3447) or TAVI (n = 2269) at our Centre between 01/2012 and 12/2018 were analysed. Diagnosis of PVE was based on Duke criteria modified in 2015. Incidence, risk factors, pathogens, impact of complications or therapy on mortality were analysed and compared between SAVR- and TAVI-PVE.Results PVE incidence did not differ significantly after SAVR with 4.9/100 patient-years and TAVI with 2.4/100 patient-years (p = 0.49), although TAVI patients were older (mean 80 vs. 67 years) and had more comorbidities (STS score mean 5.9 vs. 1.6) (p < 0.001). TAVI prostheses with polymer showed a 4.3-fold higher risk to develop PVE than without polymer (HR 4.3; p = 0.004). Most common pathogens were staphylococci and enterococci (p > 0.05). Propensity-score matching analysis showed that the type of aortic valve replacement had no effect on the development of post-procedural PVE (p = 0.997). One-year survival was higher in TAVI-PVE patients treated with antibiotics only compared to additional surgical therapy (90.9% vs. 33.3%; p = 0.005). In SAVR-PVE patients, both therapies were comparable in terms of survival (p = 0.861). However, SAVR-PVE patients who were not operated, despite ESC-guideline recommendation, had significantly poorer one-year survival (p = 0.004).Conclusion TAVI patients did not have a significantly higher risk to develop PVE. Our data suggest that TAVI-PVE patients in contrast to SAVR-PVE patients can more often be treated with antibiotics only, presumably due to the lack of a polymeric suture ring. [GRAPHICS]
引用
收藏
页码:336 / 352
页数:17
相关论文
共 50 条
  • [41] Infective Endocarditis after Transcatheter Aortic Valve Replacement: Challenges in the Diagnosis and Management
    Zakhour, Johnny
    Allaw, Fatima
    Kalash, Suha
    Wehbe, Saliba
    Kanj, Souha S.
    PATHOGENS, 2023, 12 (02):
  • [42] Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key
    Celmeta, Bleri
    Miceli, Antonio
    HEART, 2025,
  • [43] The use of a homograft in the setting of infective endocarditis after transcatheter aortic valve replacement
    Mahesh, Balakrishnan
    Dafflisio, Gianna
    Holcomb, Ryan M.
    Mancini, Benjamin
    Soleimani, Behzad
    JTCVS TECHNIQUES, 2023, 22 : 212 - 215
  • [44] Infective Endocarditis After Transcatheter Aortic Valve Replacement: The Worst That Can Happen
    Habib, Gilbert
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (17):
  • [45] Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
    del Val, David
    Abdel-Wahab, Mohamed
    Mangner, Norman
    Durand, Eric
    Ihlemann, Nikolaj
    Urena, Marina
    Pellegrini, Costanza
    Giannini, Francesco
    Gasior, Tomasz
    Wojakowski, Wojtek
    Landt, Martin
    Auffret, Vincent
    Sinning, Jan Malte
    Cheema, Asim N.
    Nombela-Franco, Luis
    Chamandi, Chekrallah
    Campelo-Parada, Francisco
    Munoz-Garcia, Erika
    Herrmann, Howard C.
    Testa, Luca
    Won-Keun, K.
    Castillo, Juan Carlos
    Alperi, Alberto
    Tchetche, Didier
    Bartorelli, Antonio L.
    Kapadia, Samir
    Stortecky, Stefan
    Amat-Santos, Ignacio
    Wijeysundera, Harindra C.
    Lisko, John
    Gutierrez-Ibanes, Enrique
    Serra, Vicenc
    Salido, Luisa
    Alkhodair, Abdullah
    Vendramin, Igor
    Chakravarty, Tarun
    Lerakis, Stamatios
    Vilalta, Victoria
    Regueiro, Ander
    Romaguera, Rafael
    Kappert, Utz
    Barbanti, Marco
    Masson, Jean-Bernard
    Maes, Frederic
    Fiorina, Claudia
    Miceli, Antonio
    Kodali, Susheel
    Ribeiro, Henrique B.
    Mangione, Jose Armando
    de Brito Jr, Fabio Sandoli
    CANADIAN JOURNAL OF CARDIOLOGY, 2022, 38 (01) : 102 - 112
  • [46] Readmission Rates Associated With Infective Endocarditis After Transcatheter Aortic Valve Replacement
    Viquez, Karolina
    Kudaravalli, Praneeth
    Woods, Elizabeth
    Gullapalli, Nageshwara
    Doshi, Rajkumar
    CIRCULATION, 2019, 140
  • [47] Endocarditis after Transcatheter Aortic Valve Replacement
    Braghieri, Lorenzo
    Kaur, Simrat
    Black, Christopher K.
    Cremer, Paul C.
    Unai, Shinya
    Kapadia, Samir R.
    Mentias, Amgad
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [48] Repair versus replacement of the aortic valve in active infective endocarditis
    Mayer, Katharina
    Aicher, Diana
    Feldner, Susanne
    Kunihara, Takashi
    Schaefers, Hans-Joachim
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 42 (01) : 122 - 127
  • [49] Transcatheter aortic valve replacement: a palliative approach to infective endocarditis
    Shen, Christine P.
    Munsayac, Marissa A.
    Robinson, Austin A.
    Stinis, Curtiss T.
    BMJ CASE REPORTS, 2022, 15 (05)
  • [50] Infective Endocarditis Following Aortic Valve Replacement: A Systematic Review
    Slouha, Ethan
    Rood, Catherine
    Burle, Venkata Sathya
    Al-Geizi, Hanin
    Clunes, Lucy A.
    Kollias, Theofanis F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)